The field of telemedicine – a term used to describe technology-based or facilitated interventions (contrasted with conventional face-to-face interventions) – has made growing contributions to clinical addiction research.
The field of telemedicine – a term used to describe technology-based or facilitated interventions (contrasted with conventional face-to-face interventions) – has made growing contributions to clinical addiction research.
l
However, community treatment programs have not widely adopted these evidence-based telemedicine applications due to several barriers including the prevailing insurance reimbursement model that typically does not cover these services.
The current study sought to examine facilitators of and barriers to integrating telemedicine into addiction treatment programs in 5 states (Iowa, Maryland, Massachusetts, Oklahoma, South Carolina) and 1 county (San Mateo) as part of the Substance Abuse and Mental Health Services Administration-funded Strengthening Treatment Access and Retention – State Implementation (SAMHSA-funded STAR-SI) program.
In the current study, each state/county was represented by groups of payers who oversee federal and state funding for substance use disorder treatment programs.
In addition to selecting telemedicine applications and developing a proposal to implement these applications, payers identified facilitators and barriers to implementation. Researchers used Eisenhardt’s iterative Process of Building Theory from Case Study Research, which focuses on using qualitative data from individual cases to build a testable set of hypotheses (see here for more information on this qualitative analysis procedure).
Apart from South Carolina and San Mateo county (California), states had already been using telemedicine applications in clinical practice, including telephone-based services, videoconferencing, and a web application called Recoveration which facilitates online communication between therapists and patients between sessions.
Anticipated benefits of telemedicine applications that were chosen for the STAR-SI project included enhanced reach to patients who might not otherwise be able to access treatment and increased recovery support between sessions.
Facilitators to implementation included:
Barriers to implementation included:
Qualitative studies like this one could inform research that evaluates the effect of implementing evidence-based telemedicine applications in real-world clinical settings on patient outcomes.
The study highlighted the challenges of adoption of evidence-based telemedicine applications in real-world health care systems that operate in a third-party payer model (e.g., billing insurance companies for individual services rendered).
Enhancing treatment and recovery through evidence-based telemedicine applications may be a complex and multi-step process. This process is informed by clinical research and ultimately requires a collaborative effort by funding sources, community treatment programs, policy makers, and third-party payers.
The next steps include evaluating the extent to which real-world clinical settings adopt these services, patient satisfaction and engagement with these services, and measuring the effect of their implementation on patient outcomes over time.
Molfenter, T., Boyle, M., Holloway, D., & Zwick, J. (2015). Trends in telemedicine use in addiction treatment. Addict Sci Clin Pract, 10, 14. doi:10.1186/s13722-015-0035-4
l
However, community treatment programs have not widely adopted these evidence-based telemedicine applications due to several barriers including the prevailing insurance reimbursement model that typically does not cover these services.
The current study sought to examine facilitators of and barriers to integrating telemedicine into addiction treatment programs in 5 states (Iowa, Maryland, Massachusetts, Oklahoma, South Carolina) and 1 county (San Mateo) as part of the Substance Abuse and Mental Health Services Administration-funded Strengthening Treatment Access and Retention – State Implementation (SAMHSA-funded STAR-SI) program.
In the current study, each state/county was represented by groups of payers who oversee federal and state funding for substance use disorder treatment programs.
In addition to selecting telemedicine applications and developing a proposal to implement these applications, payers identified facilitators and barriers to implementation. Researchers used Eisenhardt’s iterative Process of Building Theory from Case Study Research, which focuses on using qualitative data from individual cases to build a testable set of hypotheses (see here for more information on this qualitative analysis procedure).
Apart from South Carolina and San Mateo county (California), states had already been using telemedicine applications in clinical practice, including telephone-based services, videoconferencing, and a web application called Recoveration which facilitates online communication between therapists and patients between sessions.
Anticipated benefits of telemedicine applications that were chosen for the STAR-SI project included enhanced reach to patients who might not otherwise be able to access treatment and increased recovery support between sessions.
Facilitators to implementation included:
Barriers to implementation included:
Qualitative studies like this one could inform research that evaluates the effect of implementing evidence-based telemedicine applications in real-world clinical settings on patient outcomes.
The study highlighted the challenges of adoption of evidence-based telemedicine applications in real-world health care systems that operate in a third-party payer model (e.g., billing insurance companies for individual services rendered).
Enhancing treatment and recovery through evidence-based telemedicine applications may be a complex and multi-step process. This process is informed by clinical research and ultimately requires a collaborative effort by funding sources, community treatment programs, policy makers, and third-party payers.
The next steps include evaluating the extent to which real-world clinical settings adopt these services, patient satisfaction and engagement with these services, and measuring the effect of their implementation on patient outcomes over time.
Molfenter, T., Boyle, M., Holloway, D., & Zwick, J. (2015). Trends in telemedicine use in addiction treatment. Addict Sci Clin Pract, 10, 14. doi:10.1186/s13722-015-0035-4
l
However, community treatment programs have not widely adopted these evidence-based telemedicine applications due to several barriers including the prevailing insurance reimbursement model that typically does not cover these services.
The current study sought to examine facilitators of and barriers to integrating telemedicine into addiction treatment programs in 5 states (Iowa, Maryland, Massachusetts, Oklahoma, South Carolina) and 1 county (San Mateo) as part of the Substance Abuse and Mental Health Services Administration-funded Strengthening Treatment Access and Retention – State Implementation (SAMHSA-funded STAR-SI) program.
In the current study, each state/county was represented by groups of payers who oversee federal and state funding for substance use disorder treatment programs.
In addition to selecting telemedicine applications and developing a proposal to implement these applications, payers identified facilitators and barriers to implementation. Researchers used Eisenhardt’s iterative Process of Building Theory from Case Study Research, which focuses on using qualitative data from individual cases to build a testable set of hypotheses (see here for more information on this qualitative analysis procedure).
Apart from South Carolina and San Mateo county (California), states had already been using telemedicine applications in clinical practice, including telephone-based services, videoconferencing, and a web application called Recoveration which facilitates online communication between therapists and patients between sessions.
Anticipated benefits of telemedicine applications that were chosen for the STAR-SI project included enhanced reach to patients who might not otherwise be able to access treatment and increased recovery support between sessions.
Facilitators to implementation included:
Barriers to implementation included:
Qualitative studies like this one could inform research that evaluates the effect of implementing evidence-based telemedicine applications in real-world clinical settings on patient outcomes.
The study highlighted the challenges of adoption of evidence-based telemedicine applications in real-world health care systems that operate in a third-party payer model (e.g., billing insurance companies for individual services rendered).
Enhancing treatment and recovery through evidence-based telemedicine applications may be a complex and multi-step process. This process is informed by clinical research and ultimately requires a collaborative effort by funding sources, community treatment programs, policy makers, and third-party payers.
The next steps include evaluating the extent to which real-world clinical settings adopt these services, patient satisfaction and engagement with these services, and measuring the effect of their implementation on patient outcomes over time.
Molfenter, T., Boyle, M., Holloway, D., & Zwick, J. (2015). Trends in telemedicine use in addiction treatment. Addict Sci Clin Pract, 10, 14. doi:10.1186/s13722-015-0035-4